Treatment of Binge Eating Disorder in Obesity: Naltrexone/ Bupropion Combination Versus Placebo
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of the combination of Naltrexone and Bupropion
relative to placebo for reducing binge eating in persons with obesity and binge eating
disorder.
Phase:
N/A
Details
Lead Sponsor:
Yale University
Treatments:
Bupropion Bupropion hydrochloride, naltrexone hydrochoride drug combination Naltrexone